Marc Odrich, MD
Ophthalmology · Charlottesville, VANPI 1174675631
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $471,699 of the $496,968 with a category attached, or 94.9%. Johnson & Johnson Surgical Vision, Inc. accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $256,589 and has fallen 97.3% since, to $6,847 in 2024. Among ophthalmology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $3125.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$497K
- Glaukos Corporation$100
What the payments were for
- Consulting fees$471,69995%
- Travel & lodging$23,8745%
- Food & beverage$1,3950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 158 | $496,868 |
| Glaukos Corporation | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IDESIGN RS$89,889
- STAR S4 IR$88,428
- iDesign Advanced Wavescan Studio$66,845
- iFS Advanced Femtosecond Laser$62,553
- WaveScan WaveFront System$62,012
- INTRALASE FS FEMTOSEC LASER$59,570
- STAR S4 IR Excimer Laser System$16,112
- IntralAse FS Laser$9,297
- IFS ADVANCED FEMTOSEC LASER$475
How this compares
$496,968 in reported general payments places this provider in the 95th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 25 | $17,775 |
| RestasisCyclosporine | 18 | $11,514 |
| Fluorometholone | 27 | $1,733 |
| ErythromycinErythromycin Base | 134 | $1,304 |
| Doxycycline Hyclate | 47 | $496 |
| Brimonidine Tartrate | 24 | $397 |
| Timolol Maleate | 11 | $53 |
| Azithromycin | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Charlottesville
- Jayakrishna AmbatiCharlottesville$116K
- Albert JunCharlottesville$49K
- Peter NetlandCharlottesville$35K
- James GigantelliCharlottesville$10K
- Arthi VenkatCharlottesville$9K
- Andrew PittnerCharlottesville$5K
- Ethnie JonesRichmond$2M
- Elizabeth Yeu-LinNorfolk$1.7M
- John SheppardNorfolk$1.1M
- Constance OkekeNorfolk$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.